← Back to patent-cliff list
JKN-2501
Tier C — Watch / tradeJKN-2501
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Ventilator-associated pneumonia, Hospital-acquired pneumonia, Urinary tract infection, Intra-abdominal infection, Respiratory tract infection, Bacterial infection
Regional status
US
-
EU
-
China
Phase II
2026-07-24
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of JKN-2501?
Approved indications include: Ventilator-associated pneumonia, Hospital-acquired pneumonia, Urinary tract infection, Intra-abdominal infection, Respiratory tract infection, Bacterial infection.
When does the JKN-2501 patent expire?
No public expiry year is available for JKN-2501 yet; this page updates once verified.
How do I get a quote for JKN-2501 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29